191 related articles for article (PubMed ID: 26054124)
1. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Senol T; Kahramanoglu I; Dogan Y; Baktiroglu M; Karateke A; Suer N
Clin Exp Obstet Gynecol; 2015; 42(2):224-7. PubMed ID: 26054124
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Kriplani A; Awasthi D; Kulshrestha V; Agarwal N
Int J Gynaecol Obstet; 2012 Jan; 116(1):35-8. PubMed ID: 21959070
[TBL] [Abstract][Full Text] [Related]
3. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
6. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
7. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.
Mercorio F; De Simone R; Di Spiezio Sardo A; Cerrota G; Bifulco G; Vanacore F; Nappi C
Contraception; 2003 Apr; 67(4):277-80. PubMed ID: 12684148
[TBL] [Abstract][Full Text] [Related]
8. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Murat Naki M; Tekcan C; Ozcan N; Cebi M
Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
[TBL] [Abstract][Full Text] [Related]
10. The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Machado RB; de Souza IM; Beltrame A; Bernardes CR; Morimoto MS; Santana N
Gynecol Endocrinol; 2013 May; 29(5):492-5. PubMed ID: 23461277
[TBL] [Abstract][Full Text] [Related]
11. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
[TBL] [Abstract][Full Text] [Related]
13. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
Monteiro I; Bahamondes L; Diaz J; Perrotti M; Petta C
Contraception; 2002 May; 65(5):325-8. PubMed ID: 12057782
[TBL] [Abstract][Full Text] [Related]
15. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
16. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine device use among women with uterine fibroids: a systematic review.
Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
[TBL] [Abstract][Full Text] [Related]
18. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
19. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
Grigorieva V; Chen-Mok M; Tarasova M; Mikhailov A
Fertil Steril; 2003 May; 79(5):1194-8. PubMed ID: 12738516
[TBL] [Abstract][Full Text] [Related]
20. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]